Literature DB >> 27956192

Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).

Neeraj K Garg1, Gajanand Sharma1, Bhupinder Singh2, Pradip Nirbhavane1, Rajeev K Tyagi3, Rahul Shukla1, O P Katare4.   

Abstract

Present study was designed to prepare and characterize aceclofenac loaded nanostructured lipid carriers (NLCs) employing Quality by Design (QbD)-oriented approach. The NLCs were evaluated for their transdermal penetration potential and stability. Aceclofenac loaded nanostructured lipid carriers (NLCs) were prepared & characterized, by employing Quality by Design (QbD)-oriented approach and further evaluated for transdermal penetration potential and stability. Different lipids and surfactants were chosen to prepare NLCs using microemulsion method as critical material attributes (CMAs). A 33 factorial design was used for optimization of NLCs, and evaluating them for different critical quality attributes (CQAs), viz. particle size, polydispersity index (PDI), zeta potential, in vitro drug release, entrapment efficiency. The effect of CMAs such as lipids, oil: lipid ratio and concentration of surfactants on CQAs viz. drug entrapment efficiency and particle size were systematically evaluated to optimize NLCs. The optimized NLCs were further incorporated into carbopol gel and characterized for texture and rheology profile followed by in vitro and in vivo evaluations. The optimized ACE-NLCs were found to be spherical, nanometric in size with higher drug loading and entrapment efficiency. Results of the in vitro drug release study showed that the developed formulation followed Korsmeyer-Peppas model showing Fickian diffusion. The release was biphasic i.e., initial burst release followed by sustained drug release upto 48h. The optimized NLCs-based gel formulation showed superior texture, rheological profile and showed better cell uptake efficiency on hyperkeratinocytic cells (HaCaT cell lines) with higher ex vivo skin permeability efficiency vis-à-vis marketed formulation. In conclusion, dermatokinetic modeling and pharmacodynamic study using carrageenan induced edema mice suggests that aceclofenac loaded NLCs hydrogel may provide a better delivery alternative to target various skin layers.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aceclofenac; Nanostructured lipid carriers (NLCs); Optimization; Quality by Design (QbD)

Mesh:

Substances:

Year:  2016        PMID: 27956192     DOI: 10.1016/j.ijpharm.2016.12.010

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach.

Authors:  Ketki Bhise; Sushil Kumar Kashaw; Samaresh Sau; Arun K Iyer
Journal:  Int J Pharm       Date:  2017-05-11       Impact factor: 5.875

2.  Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.

Authors:  Sara Cunha; Cláudia Pina Costa; Joana A Loureiro; Jorge Alves; Andreia F Peixoto; Ben Forbes; José Manuel Sousa Lobo; Ana Catarina Silva
Journal:  Pharmaceutics       Date:  2020-06-28       Impact factor: 6.321

3.  Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.

Authors:  Zaijin Teng; Miao Yu; Yang Ding; Huaqing Zhang; Yan Shen; Menglao Jiang; Peixin Liu; Yaw Opoku-Damoah; Thomas J Webster; Jianping Zhou
Journal:  Int J Nanomedicine       Date:  2018-12-21

4.  Quality by Design Approach Using Multiple Linear and Logistic Regression Modeling Enables Microemulsion Scale Up.

Authors:  Michele Herneisey; Eric Lambert; Allison Kachel; Emma Shychuck; James K Drennen; Jelena M Janjic
Journal:  Molecules       Date:  2019-05-30       Impact factor: 4.411

5.  Nanostructured Lipid Carrier-Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases.

Authors:  Neeraj K Garg; Nikunj Tandel; Sanjay Kumar Bhadada; Rajeev K Tyagi
Journal:  Front Pharmacol       Date:  2021-09-20       Impact factor: 5.988

6.  Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization.

Authors:  Ali Sartaj; Largee Biswas; Anita Kamra Verma; P K Sahoo; Sanjula Baboota; Javed Ali
Journal:  Biomed Res Int       Date:  2022-02-03       Impact factor: 3.411

7.  Niosomal Nanocarriers for Enhanced Dermal Delivery of Epigallocatechin Gallate for Protection against Oxidative Stress of the Skin.

Authors:  Danhui Li; Nataly Martini; Zimei Wu; Shuo Chen; James Robert Falconer; Michelle Locke; Zhiwen Zhang; Jingyuan Wen
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.